DEBEL MARLENE 4

What Happened
Marlene Debel, EVP and Chief Risk Officer of MetLife (MET), exercised stock options and sold the resulting 21,312 shares on June 1, 2026. She exercised 10,600 options at $46.85 (cost $496,610) and 10,712 options at $45.50 (cost $487,396), paying a total exercise cost of $984,006. The 21,312 shares were sold in the open market at a weighted average price of $81.59 for aggregate proceeds of $1,738,823 — a pre-tax net difference of about $754,817 versus the exercise cost. Transaction codes: M = option exercise, S = sale.

Key Details

• Transaction date: June 1, 2026 (reported on Form 4 filed June 3, 2026).
• Option exercises: 10,600 shares @ $46.85 ($496,610) and 10,712 shares @ $45.50 ($487,396).
• Sale: 21,312 shares @ weighted avg $81.59, proceeds $1,738,823 (prices ranged $81.57–$81.65 per footnote).
• Net proceeds (proceeds minus exercise cost): ≈ $754,817 (pre-tax).
• Shares owned after transaction: not specified in the provided filing.
• Footnotes: F1 notes the sale price is a weighted average; F2 and F3 state the options vested in earlier years (installments in 2018–2021), indicating these were previously-granted, vested options.
• Filing timeliness: Form reports transactions for June 1 and was filed June 3 (no late-filing indicator provided).

Context
This was a common cashless-style sequence: exercised vested options (paid exercise price), then sold the acquired shares in the open market. Such transactions often convert option value to cash and do not by themselves signal a change in sentiment about the company.